MINHONG CAI

Associate

Minhong Cai is an associate of the RuiMin team. Her primary practice areas include M&A, private equity and general corporate matters.

Prior to joining RuiMin, Minhong worked atthe leading Chinese firmFangda Partners for two2 years.

Minhong speaks fluent English, Mandarin and Cantonese.

Experience
- Advising AstraZeneca on its US$1.2bn acquisition of Nasdaq-listed Gracell Biotechnology (ALB China 2024 M&A Deal of the Year Award)
- Advising CVC Capital Partners, on its acquisition of Scan Global Logistics (SGL),a global full-service logistics provider,with an enterprise value of US$1.67leading international freight forwarder, Scan Global Logistics. The gross valuation of the deal is US$1.5bn
- Advising Ericsson (NASDAQ:ERIC), the world's largest mobile communication equipment provider, on the sale of its Internet of Things Accelerator (IoTA) and Connected Vehicle Cloud (CVC) businesses to Aeris Communications, Inc
- Advising Cainiao on its US$67m investment in De Well Group, a leading international freight forwarder
- Advising Midea Group (000333.SZ) on its RMB2.3bn acquisition of the controlling stake of Wandong Medical (600055.SH)
- Advising Lumentum Holdings Inc. (NASDAQ: LITE) on its US$918m acquisition of NeoPhotonics Corporation (NYSE:NPTN)
- Advising Sandvik Machining Solutions AB on its acquisition of Suzhou Ahno Group, a group leading in the precision cutting tool industry of China
Qualifications

Minhong graduated from China University of Politics & Law where she obtained LLB and LLM degrees.